NASDAQ
KalVista Pharmaceuticals, Inc. (KALV) has a current ratio of 5.58x as of Monday, May 25, 2026. This represents a 48.60% decrease compared to its 12-month average of 10.86x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.